Paid Clinical Trials in Stony Brook, NY
As of August 2026, 173 paid clinical trials are recruiting in Stony Brook, New York. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Stony Brook offers studies at sites including Stony Brook University Medical Center for conditions such as Acute Myeloid Leukemia, Breast Cancer, Anatomic Stage II Breast Cancer AJCC v8, Acute Myeloid Leukemia Post Cytotoxic Therapy. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Stony Brook
Trials by drug in Stony Brook
Filter results
Newly added in Stony Brook
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Vagus Nerve Stimulation in Patients in Comatose State
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
168 clinical trials
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
SELUTION 4 De Novo Small Vessel IDE Trial
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Nectero EAST System Clinical Study
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Global Paradise System US Post Approval Study
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Top Research Study Locations in Stony Brook
Researchers run research studies in Stony Brook, NY at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Stony Brook University Medical Center | Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, Acute Myeloid Leukemia Post Cytotoxic Therapy | 64 |
| Stony Brook University Hospital | Intracerebral Hemorrhage, Aneurysm, Intracranial, Anxiety | 33 |
| Stony Brook University | Opioid Use Disorder, Aneurysm, Brain, Atrial Fibrillation | 14 |
| Stony Brook Medicine | Focal Epilepsy, Hypertension, Abdominal Aortic Aneurysm | 12 |
| Stony Brook University Cancer Center | Breast Cancer, Breast Adenocarcinoma, Cancer Survivors | 6 |
| Stony Brook Cancer Center | Acute Myeloid Leukemia, AML, AML With Mutated NPM1 | 4 |
| GSK Investigational Site | HIV Infections, Multiple Myeloma, Newly Diagnosed Multiple Myeloma | 2 |
| Nkarta Investigational Site | Antineutrophil Cytoplasmic Antibody-Associated Vasculitis, Idiopathic Inflammatory Myopathies, Lupus Nephritis | 2 |
| Stony Brook Children's Hospital | Congenital CMV Infection, Failed or Difficult Intubation, Sequela, Intubation Complication | 2 |
| Stony Brook University: Dept of Psychiatry | Major Depressive Disorder (MDD) | 2 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| Ascentage Investigative | Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Ph+ ALL | 1 |
| DermResearchCenter of New York | Acne Vulgaris | 1 |
| Elyse S. Rafal, MD PC - Rafal Center for Dermatology & Cosmetic Surgery | Plaque Psoriasis | 1 |
| Local Institution - 0221 | Relapsed or Refractory Multiple Myeloma (RRMM) | 1 |
| Renaissance School of Medicine Stony Brook University | Cesarean Delivery, General Anesthesia | 1 |
| SUNY Stony Brook | Hepatitis C | 1 |
| Site 5040, SUNY Stony Brook NICHD CRS | Pregnancy | 1 |
| Stony Brook | Vein Disease, Vein Occlusion, Vein Thrombosis | 1 |
| Stony Brook Advanced Specialty Care | Interstitial Lung Disease, Progressive Pulmonary Fibrosis | 1 |
| Stony Brook Breast Center | Breast Cancer, HER2-positive Breast Cancer, Locally Advanced Breast Cancer | 1 |
| Stony Brook Cancer Center | Non-Small Cell Lung Cancer | 1 |
| Stony Brook Heart Institute | Tricuspid Regurgitation, Tricuspid Regurgitation Functional | 1 |
| Stony Brook Hospital | Basal Cell Carcinoma, Skin Cancer, Squamous Cell Carcinoma | 1 |
| Stony Brook Orthopaedics | Carpometacarpal (CMC) Osteoarthritis | 1 |
Active & Upcoming Studies in Stony Brook (2026)
Recruiting trials in Stony Brook grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (87 active studies)
- Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial · Phase 3 · National Cancer Institute (NCI)
- Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer · Phase 2 · National Cancer Institute (NCI)
Cardiovascular (14 active studies)
- Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258) · Phase 3 · Reprieve Cardiovascular, Inc
- The VENTOR Clinical Study · CoLabs Medical
Neurology & pain (11 active studies)
HIV / STI (2 active studies)
- Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV · Phase 1, Phase 2 · National Institute of Allergy and Infectious Diseases (NIAID)
- A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed · Phase 3 · ViiV Healthcare
Mental health & behavior (2 active studies)
Vaccines (1 active study)
Pediatric (1 active study)
- Monetary Incentive Delay Task for Probing Reward-related Neural Processes · Stony Brook University
Common conditions studied in Stony Brook
- Acute Myeloid Leukemia (11 active studies)
- Breast Cancer (7 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies)
- Acute Myeloid Leukemia Post Cytotoxic Therapy (3 active studies)
- Heart Failure (3 active studies)
- Intracerebral Hemorrhage (3 active studies)
Leading research sponsors in Stony Brook
- National Cancer Institute (NCI)
- Stony Brook University
- Children's Oncology Group
- AstraZeneca
- Alliance for Clinical Trials in Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Stony Brook?
There are approximately 173 recruiting clinical trials in Stony Brook, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Stony Brook pay participants?
Most recruiting trials in Stony Brook compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Stony Brook?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Stony Brook?
The most common conditions under active study in Stony Brook include Acute Myeloid Leukemia (11), Breast Cancer (7), Anatomic Stage II Breast Cancer AJCC v8 (4), Acute Myeloid Leukemia Post Cytotoxic Therapy (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Stony Brook?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Stony Brook on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Stony Brook?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Stony Brook?
Recruiting research sites in Stony Brook include Stony Brook University Medical Center, Stony Brook University Hospital, Stony Brook University, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Stony Brook right now?
The largest active categories in Stony Brook are Cancer & tumors (87), Cardiovascular (14), Neurology & pain (11). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.